[11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET
- PMID: 8366755
- DOI: 10.1016/0024-3205(93)90440-e
[11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET
Abstract
The in vivo behavior of the stereoisomers of [11C]McN5652, a highly potent serotonin (5-HT) uptake blocker, was determined to evaluate their utility as radiotracers for imaging 5-HT uptake sites by positron emission tomography (PET). After intravenous injection into mice, [11C](+)McN5652 showed markedly higher uptake and longer retention in regions with high density of 5-HT uptake sites than the [11C]-labeled racemic mixture, while [11C](-)McN5652 washed out rapidly. With the [11C](+)-enantiomer, the ratio between hypothalamus and cerebellum reached 6 at 90 minutes. The binding of [11C](+)McN5652 was inhibited by 45-73% by pre-injection of 5 mg/kg of paroxetine, a selective 5-HT uptake blocker, in all regions examined except cerebellum where no significant effect of the drug was observed. [11C](-)McN5652 showed no specific binding in any of the regions. The [11C]-labeled cis isomer, [11C]McN5655, revealed surprisingly low brain penetration and showed no significantly higher uptake in regions of interest than cerebellum. These results suggest that [11C](+)McN5652 is a promising candidate as a PET radiotracer for studying 5-HT uptake sites in vivo.
Similar articles
-
Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652.Synapse. 1995 May;20(1):37-43. doi: 10.1002/syn.890200107. Synapse. 1995. PMID: 7624828 Clinical Trial.
-
Positron emission tomography of 5-HT transporter sites in the baboon brain with [11C]McN5652.J Cereb Blood Flow Metab. 1995 Sep;15(5):798-805. doi: 10.1038/jcbfm.1995.100. J Cereb Blood Flow Metab. 1995. PMID: 7673372
-
A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z.J Nucl Med. 1993 Jan;34(1):120-7. J Nucl Med. 1993. PMID: 8418252
-
Positron emission tomography imaging of the serotonin transporter in the pig brain using [11C](+)-McN5652 and S-([18F]fluoromethyl)-(+)-McN5652.Synapse. 2003 Feb;47(2):143-51. doi: 10.1002/syn.10163. Synapse. 2003. PMID: 12454952
-
Development of PET/SPECT ligands for the serotonin transporter.NIDA Res Monogr. 1994;138:111-30. NIDA Res Monogr. 1994. PMID: 7603538 Review.
Cited by
-
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1001-11. doi: 10.1007/s00259-012-2078-z. Epub 2012 Feb 17. Eur J Nucl Med Mol Imaging. 2012. PMID: 22349718 Clinical Trial.
-
Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review.Front Neurosci. 2022 Apr 13;16:806876. doi: 10.3389/fnins.2022.806876. eCollection 2022. Front Neurosci. 2022. PMID: 35495051 Free PMC article. Review.
-
Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.J Cereb Blood Flow Metab. 1999 Sep;19(9):967-81. doi: 10.1097/00004647-199909000-00004. J Cereb Blood Flow Metab. 1999. PMID: 10478648 Free PMC article.
-
The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders.J Biomed Biotechnol. 2011;2011:439397. doi: 10.1155/2011/439397. Epub 2011 Mar 22. J Biomed Biotechnol. 2011. PMID: 21541178 Free PMC article. Review.
-
Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.J Cereb Blood Flow Metab. 2013 Dec;33(12):1886-96. doi: 10.1038/jcbfm.2013.134. Epub 2013 Aug 7. J Cereb Blood Flow Metab. 2013. PMID: 23921898 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
